Page last updated: 2024-09-04

ym 872 and Brain Ischemia

ym 872 has been researched along with Brain Ischemia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anraku, T; Asano, J; Hori, W; Shiga, F; Takano, Y; Uno, T1
Kawasaki-Yatsugi, S; Kohara, A; Ni, JW; Okada, M; Sakamoto, S; Shimizu-Sasamata, M; Shishikura, J; Takahashi, M; Yamaguchi, T; Yatsugi, S1
Kawasaki-Yatsugi, S; Koshiya, K; Ni, JW; Sakamoto, S; Shimizu-Sasamata, M; Shishikura, JI; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, SI1
Ichiki, C; Kawasaki-Yatsugi, S; Minematsu, K; Shimizu-Sasamata, M; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, S1
Kano, T; Lo, EH; Moskowitz, MA; Rogowska, J; Shimizu-Sasamata, M; Wolf, GL1
Ichiki, C; Kawasaki-Yatsugi, S; Koshiya, K; Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, SI1
Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S1
Ichiki, C; Kawasaki-Yatsugi, S; Minematsu, K; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S1
Lo, EH; Moskowitz, MA; Sasamata, M1

Reviews

2 review(s) available for ym 872 and Brain Ischemia

ArticleYear
YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist.
    CNS drug reviews, 2002,Winter, Volume: 8, Issue:4

    Topics: Animals; Brain Ischemia; Cats; Clinical Trials, Phase I as Topic; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Imidazoles; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Quinoxalines; Rats; Receptors, AMPA; Solubility; Stroke

2002
[New method for evaluating the effects of neuroprotective therapy in the hemodynamic penumbra].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2000, Volume: 115, Issue:3

    Topics: Animals; Brain Ischemia; Endothelium, Vascular; Hemodynamics; Imidazoles; Mice; Mice, Knockout; Neuroprotective Agents; Nitric Oxide Synthase; Quinoxalines; Rats; Receptors, AMPA; Tomography, X-Ray Computed

2000

Other Studies

7 other study(ies) available for ym 872 and Brain Ischemia

ArticleYear
Synthesis and AMPA receptor antagonistic activity of a novel 7-imidazolyl-6-trifluoromethyl quinoxalinecarboxylic acid with a substituted phenyl group and improved its good physicochemical properties by introduced CF3 group.
    Bioorganic & medicinal chemistry letters, 2004, Oct-18, Volume: 14, Issue:20

    Topics: Animals; Brain Ischemia; Disease Models, Animal; Imidazoles; In Vitro Techniques; Infusions, Intravenous; Neuroprotective Agents; Quinoxalines; Rats; Receptors, AMPA; Solubility; Structure-Activity Relationship

2004
YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 284, Issue:2

    Topics: Animals; Brain; Brain Ischemia; Cats; Cerebral Cortex; Corpus Striatum; Imidazoles; Male; Neuroprotective Agents; Quinoxalines; Receptors, AMPA; Regional Blood Flow

1998
A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Brain research, 1998, May-18, Volume: 793, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Blood Gas Analysis; Body Temperature; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Infusions, Intravenous; Kidney; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors

1998
YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats.
    Stroke, 1998, Volume: 29, Issue:10

    Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Hemodynamics; Imidazoles; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Solubility; Time Factors; Tomography, X-Ray Computed; Water

1998
Neuroprotective efficacy of YM872, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:2

    Topics: Animals; Brain Ischemia; Cerebral Arteries; Excitatory Amino Acid Antagonists; Imidazoles; Male; Motor Activity; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA

1998
Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats.
    Neuroreport, 1998, Nov-16, Volume: 9, Issue:16

    Topics: Animals; Arterial Occlusive Diseases; Atrophy; Body Temperature; Body Weight; Brain Ischemia; Cerebral Infarction; Imidazoles; Male; Neurologic Examination; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Substantia Nigra

1998
Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model.
    Neuropharmacology, 2000, Jan-04, Volume: 39, Issue:2

    Topics: Animals; Brain Ischemia; Cerebral Arteries; Cerebrovascular Disorders; Imidazoles; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Reperfusion Injury

2000